Iron deficiency in patients with a Fontan circulation and its impact on exercise capacity.

Gaston van Hassel, Sean C S Rivrud, Frank J Timmerman, Peter van der Meer, Elke S Hoendermis, Eryn T Liem, Rolf M F Berger, Joost P van Melle
Author Information
  1. Gaston van Hassel: Center for Congential Heart Diseases, Department of Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands g.van.hassel@umcg.nl. ORCID
  2. Sean C S Rivrud: Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  3. Frank J Timmerman: Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  4. Peter van der Meer: Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  5. Elke S Hoendermis: Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  6. Eryn T Liem: Center for Congential Heart Diseases, Department of Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  7. Rolf M F Berger: Center for Congential Heart Diseases, Department of Paediatric Cardiology, Beatrix Children's Hospital, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  8. Joost P van Melle: Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands. ORCID

Abstract

BACKGROUND: Iron deficiency (ID) has been reported in patients with congenital heart disease. There is, however, a scarcity of data on its prevalence in patients with a Fontan circulation. The aim of this study is to investigate the prevalence of ID in Fontan patients and to investigate the association between ID and exercise capacity in this population.
METHODS AND RESULTS: Blood count and haematological parameters were determined in plasma of 61 Fontan patients (51% female, mean age 29��9 years). ID was defined as transferrin saturation (TSAT) ���19.8%. The prevalence of ID was 36% (22/61 patients). Especially among women, the diagnosis of ID was highly prevalent (52%) despite normal haemoglobin levels (153.7��18.4 g/L). Mean ferritin levels were 98��80 ��g/L and mean TSAT levels were 22%��12%. Cardiopulmonary exercise testing was performed in 46 patients (75%). Patients with ID had a lower peak oxygen uptake (V��Opeak) (1397��477 vs 1692��530 mL/min; p=0.039), although this relationship was confounded by sex. The presence of ID increased the likelihood of not achieving a respiratory exchange ratio (RER) ���1.1 by 5-fold (p=0.035).
CONCLUSION: ID is highly prevalent among patients with a Fontan circulation. V��Opeak is lower in patients with ID. Fontan patients with ID are less likely to achieve an RER���1.1 during cardiopulmonary exercise testing.

Keywords

References

  1. PLoS Med. 2019 Jun 6;16(6):e1002818 [PMID: 31170159]
  2. Congenit Heart Dis. 2013 Mar-Apr;8(2):117-23 [PMID: 22891845]
  3. Lancet. 2021 Jan 16;397(10270):233-248 [PMID: 33285139]
  4. Circulation. 2010 Jan 5;121(1):34-42 [PMID: 20026781]
  5. Am J Physiol Endocrinol Metab. 2000 Dec;279(6):E1325-34 [PMID: 11093921]
  6. Eur J Cardiothorac Surg. 2014 Apr;45(4):602-9 [PMID: 24067749]
  7. Nephrol Dial Transplant. 2021 Dec 2;36(12):2342-2344 [PMID: 33944947]
  8. Eur Heart J. 2010 Dec;31(24):3073-83 [PMID: 20929979]
  9. N Engl J Med. 2009 Dec 17;361(25):2436-48 [PMID: 19920054]
  10. Sports Med. 2022 Nov;52(11):2775-2795 [PMID: 35829994]
  11. Eur Heart J. 2023 Oct 1;44(37):3627-3639 [PMID: 37622666]
  12. Am Heart J. 2003 Jun;145(6):1102-7 [PMID: 12796770]
  13. Med Sci Sports Exerc. 2014 Jan;46(1):10-5 [PMID: 23846156]
  14. Cardiol Young. 2023 Nov;33(11):2334-2341 [PMID: 36776115]
  15. Eur Heart J. 2012 Dec;33(23):2917-27 [PMID: 22952138]
  16. Am J Cardiol. 2006 Sep 1;98(5):666-7 [PMID: 16923458]
  17. J Cardiol. 2014 Nov;64(5):384-9 [PMID: 24698006]
  18. Am Heart J. 2013 Apr;165(4):575-582.e3 [PMID: 23537975]
  19. Am J Hematol. 2017 Jan;92(1):88-93 [PMID: 27779769]
  20. J Cardiol. 2019 Sep;74(3):223-232 [PMID: 30928109]
  21. Heart. 2016 Jul 15;102(14):1081-6 [PMID: 27220691]
  22. Eur Heart J. 2021 Sep 21;42(36):3599-3726 [PMID: 34447992]
  23. Heart. 2013 Oct;99(20):1530-4 [PMID: 23846614]
  24. J Am Coll Cardiol. 2008 Jul 8;52(2):99-107 [PMID: 18598887]
  25. Int J Cardiol. 2020 Apr 15;305:56-62 [PMID: 31959411]
  26. Cell Rep. 2013 Jan 31;3(1):237-45 [PMID: 23318259]
  27. Eur J Heart Fail. 2018 May;20(5):910-919 [PMID: 29484788]
  28. Circ Heart Fail. 2018 Feb;11(2):e004519 [PMID: 29382661]

MeSH Term

Humans
Female
Male
Fontan Procedure
Heart Defects, Congenital
Exercise Tolerance
Adult
Prevalence
Exercise Test
Young Adult
Biomarkers
Anemia, Iron-Deficiency
Oxygen Consumption
Iron
Iron Deficiencies
Adolescent
Ferritins

Chemicals

Biomarkers
Iron
Ferritins

Word Cloud

Created with Highcharts 10.0.0IDpatientsFontanexerciseprevalencecirculationlevelsIrondeficiencyinvestigatecapacitymeanTSATamonghighlyprevalenttestinglowerV��Opeakp=01CongenitalBACKGROUND:reportedcongenitalheartdiseasehoweverscarcitydataaimstudyassociationpopulationMETHODSANDRESULTS:Bloodcounthaematologicalparametersdeterminedplasma6151%femaleage29��9yearsdefinedtransferrinsaturation���198%36%22/61Especiallywomendiagnosis52%despitenormalhaemoglobin1537��184g/LMeanferritin98��80��g/L22%��12%Cardiopulmonaryperformed4675%Patientspeakoxygenuptake1397��477vs1692��530mL/min039althoughrelationshipconfoundedsexpresenceincreasedlikelihoodachievingrespiratoryexchangeratioRER���15-fold035CONCLUSION:lesslikelyachieveRER���1cardiopulmonaryimpactAbnormalitiesProcedureHeartDefects

Similar Articles

Cited By